Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018.
Pre-diabetes mellitus
Type 2 diabetes
Women of childbearing age
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
08 11 2019
08 11 2019
Historique:
received:
17
03
2019
accepted:
07
10
2019
entrez:
10
11
2019
pubmed:
11
11
2019
medline:
25
8
2020
Statut:
epublish
Résumé
Investing in women's health is an inevitable investment in our future. We systematically reviewed the available evidence and summarized the weighted prevalence of type 2 diabetes (T2DM) and pre-diabetes mellitus (pre-DM) in women of childbearing age (15-49 years) in the Middle East and North African (MENA) region. We comprehensively searched six electronic databases to retrieve published literature and prevalence studies on T2DM and pre-DM in women of childbearing age in the MENA. Retrieved citations were screened and data were extracted by at least two independent reviewers. Weighted T2DM and pre-DM prevalence was estimated using the random-effects model. Of the 10,010 screened citations, 48 research reports were eligible. Respectively, 46 and 24 research reports on T2DM and pre-DM prevalence estimates, from 14 and 10 countries, were included. Overall, the weighted T2DM and pre-DM prevalence in 14 and 10 MENA countries, respectively, were 7.5% (95% confidence interval [CI], 6.1-9.0) and 7.6% (95% CI, 5.2-10.4). In women sampled from general populations, T2DM prevalence ranged from 0.0 to 35.2% (pooled, 7.7%; 95% CI, 6.1-9.4%) and pre-DM prevalence ranged from 0.0 to 40.0% (pooled, 7.9%; 95% CI, 5.3-11.0%). T2DM was more common in the Fertile Crescent countries (10.7%, 95% CI, 5.2-17.7%), followed by the Arab Peninsula countries (7.6%, 95% CI, 5.9-9.5%) and North African countries and Iran (6.5%, 95% CI, 4.3-9.1%). Pre-DM prevalence was highest in the Fertile Crescent countries (22.7%, 95% CI, 14.2-32.4%), followed by the Arab Peninsula countries (8.6%, 95% CI, 5.5-12.1%) and North Africa and Iran (3.3%, 95% CI, 1.0-6.7%). T2DM and pre-DM are common in women of childbearing age in MENA countries. The high DM burden in this vital population group could lead to adverse pregnancy outcomes and acceleration of the intergenerational risk of DM. Our review presented data and highlighted gaps in the evidence of the DM burden in women of childbearing age, to inform policy-makers and researchers. PROSPERO CRD42017069231.
Sections du résumé
BACKGROUND
Investing in women's health is an inevitable investment in our future. We systematically reviewed the available evidence and summarized the weighted prevalence of type 2 diabetes (T2DM) and pre-diabetes mellitus (pre-DM) in women of childbearing age (15-49 years) in the Middle East and North African (MENA) region.
METHODS
We comprehensively searched six electronic databases to retrieve published literature and prevalence studies on T2DM and pre-DM in women of childbearing age in the MENA. Retrieved citations were screened and data were extracted by at least two independent reviewers. Weighted T2DM and pre-DM prevalence was estimated using the random-effects model.
RESULTS
Of the 10,010 screened citations, 48 research reports were eligible. Respectively, 46 and 24 research reports on T2DM and pre-DM prevalence estimates, from 14 and 10 countries, were included. Overall, the weighted T2DM and pre-DM prevalence in 14 and 10 MENA countries, respectively, were 7.5% (95% confidence interval [CI], 6.1-9.0) and 7.6% (95% CI, 5.2-10.4). In women sampled from general populations, T2DM prevalence ranged from 0.0 to 35.2% (pooled, 7.7%; 95% CI, 6.1-9.4%) and pre-DM prevalence ranged from 0.0 to 40.0% (pooled, 7.9%; 95% CI, 5.3-11.0%). T2DM was more common in the Fertile Crescent countries (10.7%, 95% CI, 5.2-17.7%), followed by the Arab Peninsula countries (7.6%, 95% CI, 5.9-9.5%) and North African countries and Iran (6.5%, 95% CI, 4.3-9.1%). Pre-DM prevalence was highest in the Fertile Crescent countries (22.7%, 95% CI, 14.2-32.4%), followed by the Arab Peninsula countries (8.6%, 95% CI, 5.5-12.1%) and North Africa and Iran (3.3%, 95% CI, 1.0-6.7%).
CONCLUSIONS
T2DM and pre-DM are common in women of childbearing age in MENA countries. The high DM burden in this vital population group could lead to adverse pregnancy outcomes and acceleration of the intergenerational risk of DM. Our review presented data and highlighted gaps in the evidence of the DM burden in women of childbearing age, to inform policy-makers and researchers.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO CRD42017069231.
Identifiants
pubmed: 31703716
doi: 10.1186/s13643-019-1187-1
pii: 10.1186/s13643-019-1187-1
pmc: PMC6839168
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
268Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
BMJ. 2015 Jul 21;351:h3576
pubmed: 26199070
BMC Res Notes. 2012 Sep 10;5:496
pubmed: 22963905
Diabetes Res Clin Pract. 2008 Jan;79(1):147-50
pubmed: 17767973
Diabet Med. 2002 Nov;19(11):954-7
pubmed: 12421434
Ann Saudi Med. 2011 Jan-Feb;31(1):19-23
pubmed: 21245594
J Diabetes. 2015 Sep;7(5):622-32
pubmed: 25266306
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Saudi Med J. 2008 Aug;29(8):1173-8
pubmed: 18690314
Med Princ Pract. 2007;16(2):114-8
pubmed: 17303946
Can J Diabetes. 2016 Dec;40(6):570-575
pubmed: 27476052
Diabetes Care. 2007 Oct;30(10):2708-15
pubmed: 17595350
BMC Public Health. 2013 Feb 05;13:103
pubmed: 23379469
Circulation. 2007 Jul 10;116(2):151-7
pubmed: 17576864
Diabetes Res Clin Pract. 2005 Aug;69(2):188-95
pubmed: 16005369
Diabetes Res Clin Pract. 2009 Apr;84(1):99-106
pubmed: 19261345
BMC Public Health. 2008 May 24;8:176
pubmed: 18501007
Int J Clin Exp Med. 2015 Jul 15;8(7):11502-7
pubmed: 26379970
ScientificWorldJournal. 2009 Jun 12;9:424-30
pubmed: 19526180
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
Diabetologia. 2006 Feb;49(2):289-97
pubmed: 16391903
Diabet Med. 2007 Feb;24(2):200-7
pubmed: 17257284
PLoS One. 2016 Jul 14;11(7):e0159378
pubmed: 27414402
Asian Pac J Cancer Prev. 2014;15(18):7897-907
pubmed: 25292084
J Am Soc Nephrol. 2002 Jun;13(6):1626-34
pubmed: 12039992
Diabetes Care. 2000 Aug;23(8):1113-8
pubmed: 10937507
Singapore Med J. 2008 Jul;49(7):571-6
pubmed: 18695867
Clin J Am Soc Nephrol. 2010 Apr;5(4):673-82
pubmed: 20338960
PLoS One. 2012;7(10):e48153
pubmed: 23118943
Diabetes Care. 2006 Jan;29(1):26-31
pubmed: 16373891
PLoS One. 2017 Nov 21;12(11):e0187967
pubmed: 29161276
BMC Public Health. 2014 Jan 28;14:86
pubmed: 24472619
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Diabetes Res Clin Pract. 2005 Sep;69(3):279-86
pubmed: 16098925
Eur J Obstet Gynecol Reprod Biol. 2014 May;176:149-52
pubmed: 24630294
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
Clin Infect Dis. 2017 Mar 15;64(6):719-727
pubmed: 27986673
Diabetes Metab Syndr Obes. 2014 May 02;7:139-44
pubmed: 24833912
Saudi Med J. 2002 Sep;23(9):1059-63
pubmed: 12370712
Balkan Med J. 2012 Sep;29(3):247-51
pubmed: 25207009
Environ Health Perspect. 2014 Oct;122(10):1007-14
pubmed: 24968373
Obes Rev. 2011 Jan;12(1):1-13
pubmed: 20546144
J Hum Hypertens. 2005 Nov;19(11):861-8
pubmed: 16034449
Diabetes Care. 1993 Nov;16(11):1485-93
pubmed: 8299438
BMJ Open. 2014 Aug 19;4(8):e005906
pubmed: 25138813
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Eur J Obstet Gynecol Reprod Biol. 2004 Apr 15;113(2):149-53
pubmed: 15063951
Asia Pac J Clin Nutr. 2003;12(3):337-43
pubmed: 14505998
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Diabetes Res Clin Pract. 2015 Sep;109(3):493-9
pubmed: 26164090
East Mediterr Health J. 2008 Jan-Feb;14(1):42-56
pubmed: 18557451
Saudi Med J. 2000 May;21(5):438-42
pubmed: 11500677
PLoS One. 2017 Jan 18;12(1):e0169949
pubmed: 28099445
Am J Public Health. 2012 May;102(5):909-14
pubmed: 21940918
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
Public Health Nutr. 2006 Sep;9(6):722-7
pubmed: 16925877
Diabetes Care. 2008 Feb;31(2):340-6
pubmed: 18000174
Bull World Health Organ. 2007 Jan;85(1):19-26
pubmed: 17242754
Diabetes Care. 2007 Mar;30(3):753-9
pubmed: 17327355
Diabetes Res Clin Pract. 2007 Dec;78(3):369-77
pubmed: 17532085
BMC Med. 2011 Jun 20;9:76
pubmed: 21689399
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Mo Med. 2016 Sep-Oct;113(5):352-357
pubmed: 30228498
Singapore Med J. 2010 Dec;51(12):923-30
pubmed: 21221496
JAMA. 2002 May 15;287(19):2528-33
pubmed: 12020333
Syst Rev. 2018 Jul 18;7(1):96
pubmed: 30021654
Diabetologia. 2013 Jul;56(7):1520-30
pubmed: 23620057
BMC Public Health. 2018 May 18;18(1):639
pubmed: 29776343
J Thromb Thrombolysis. 2011 Nov;32(4):453-8
pubmed: 21837382
PLoS One. 2016 Mar 30;11(3):e0150120
pubmed: 27028199
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Saudi Med J. 2017 Apr;38(4):413-421
pubmed: 28397949
Child Care Health Dev. 2010 May;36(3):404-13
pubmed: 19961497
Saudi Med J. 2006 Jan;27(1):76-9
pubmed: 16432598
PLoS One. 2016 Apr 01;11(4):e0152559
pubmed: 27035920
Int J Endocrinol Metab. 2015 Apr 20;13(2):e21696
pubmed: 25892996
Metab Syndr Relat Disord. 2006 Fall;4(3):204-14
pubmed: 18370739
Nutrition. 2006 May;22(5):504-11
pubmed: 16500082
Sci Rep. 2018 May 1;8(1):6862
pubmed: 29717208
Int J Surg. 2010;8(5):336-41
pubmed: 20171303